Athersys OverviewLatest common stock for ATHX: $27K.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
The latest common stock for ATHX is $27K as of September 2023. That compares with $13K in the prior-year period — up 107.7% year over year. Investors often review this figure alongside Athersys's historical trend and sector peers before judging valuation or financial health.
Over the past year, ATHX's common stock moved from $13K to $27K — a 107.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Athersys's operating scale or balance-sheet position.
A common stock figure of $27K for ATHX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting ATHX's common stock ($27K), review year-over-year change from $13K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Athersys's common stock against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
